Immunotherapy in renal cell carcinoma: latest evidence and clinical implications

Advances in understanding the mechanisms of tumour-induced immunosuppression have led to the development of immune-checkpoint inhibitors in cancer patients, including those with renal cell carcinoma (RCC). The optimal combination between immunotherapy and targeted agents (as well as the possible fav...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Drugs Context
Main Authors: Santoni, Matteo, Massari, Francesco, Di Nunno, Vincenzo, Conti, Alessandro, Cimadamore, Alessia, Scarpelli, Marina, Montironi, Rodolfo, Cheng, Liang, Battelli, Nicola, Lopez-Beltran, Antonio
Format: Artigo
Jezik:Inglês
Izdano: BioExcel Publishing Ltd 2018
Teme:
Editorial
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992965/
https://ncbi.nlm.nih.gov/pubmed/29899754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212528
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki